Perseo pharma AG
ActiveLimited or Corporation721001 - Research and experimental development in the pharmaceutical industryperseo-pharma.com
Pharmaceuticals / Nanotechnology / BiotechPatients suffering from digestive deficiencies (e.g., pancreatitis, pancreatic cancer, cystic fibrosis) and pharmaceutical industry partners.
Perseo pharma AG is a Swiss AG registered in Muttenz, BL. Its registered activity falls under Research and experimental development in the pharmaceutical industry.
AI-enriched data· marks AI-enriched fields
AI Insight
Registry narrative generated from SHAB/SOGC facts.
Officers12Active Relations12Deleted Relations0SOGC Records16First Record22.04.2020Latest Activity24.10.2025NanotechnologyEnzyme TherapeuticsDigestive DiseasesBiotechMetabolic Therapies
Registry Information
- Swiss UID
- CHE-492.603.214
- Legal Name
- Perseo pharma AG
- Legal Form
- Limited or Corporation
- Incorporated
- 25 Mar 2019
- Share Capital
- CHF 228'029.00
- Canton
- BL
- Status
- Active
- Country
- Switzerland
Company Purpose
Translating…
NOGA Codes
(Industry classification)Research and experimental development in the pharmaceutical industry
NPROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES72Scientific research and development721Research and experimental development on natural sciences and engineering7210Research and experimental development on natural sciences and engineering721001
Industry Health
Registered Address
Hofackerstrasse 40B
4132, Muttenz, BL
Companies at this address
Enrich from integrations
Pull data from your connected providers and merge it with the registry.
Registry Pulse
Registry pulse is a Pro feature
Current Directors & Officers
From the web
Target Customers
Patients suffering from digestive deficiencies (e.g., pancreatitis, pancreatic cancer, cystic fibrosis) and pharmaceutical industry partners.
